重度心房功能性二尖瓣反流的临床与超声特征、管理及结局
本研究连续纳入2011–2018年因重度二尖瓣反流且左室功能保留而行经食管超声的患者283例,以无瓣叶病变定义心房功能性二尖瓣反流(AFMR,占14%)。与原发性二尖瓣反流(PMR)相比,AFMR患者合并症更多、E/e'更高、左房纵向应变更差,随访(中位22个月)生存更差、心衰住院更多、接受二尖瓣干预更少,且AFMR为死亡的独立相关因素(校正OR 2.61,95%CI 1.17–5.83,P=0.02)。
要点
- AFMR占重度MR伴左室功能保留者的14%,以无瓣叶病变为定义,属高危亚组。
- AFMR患者E/e'更高(中位16.04 vs 14.1)且左房纵向应变峰值更低(16.86±12.15% vs 23.67±14.09%)。
- AFMR接受二尖瓣干预比例更低(59.0% vs 83.6%),但手术与生存改善相关(log-rank P=0.021)。
核心结论
- AFMR是认识不足的高危人群,合并症多、治疗选择有限且结局差。
- AFMR与死亡率独立相关(校正OR 2.61,95%CI 1.17–5.83,P=0.02)。
- AFMR患者接受二尖瓣干预的比例低于PMR,但手术与生存改善相关。
研究设计与样本
- 单中心回顾性研究,连续纳入2011–2018年因重度二尖瓣反流且左室功能保留行经食管超声的患者。
- 共纳入283例,AFMR占14%,PMR占86%;排除感染性心内膜炎、各类心肌病及既往二尖瓣干预者。
- 以无瓣叶病变定义AFMR;结局为死亡和心衰住院;随访中位22个月。
关键影像表现/征象
- AFMR患者高血压(94.9% vs 76.2%,P=0.015)、糖尿病(46.2% vs 18.4%,P<0.001)及长期房颤(28.2% vs 13.1%,P=0.015)比例更高。
- AFMR患者既往非二尖瓣心脏手术(25.6% vs 9.8%,P=0.004)和起搏器置入(33.3% vs 13.5%,P=0.002)比例更高。
- AFMR患者平均E/e'更高(中位16.04[13.1–22.46] vs 14.1[10.89–19],P=0.036)。
- AFMR患者左房纵向应变峰值更低(16.86±12.15% vs 23.67±14.09%,P=0.002)。
诊断标准与关键数值
- AFMR定义:重度二尖瓣反流伴左室功能保留,且无瓣叶病变。
- AFMR与PMR的E/e'中位数分别为16.04(IQR 13.1–22.46)和14.1(IQR 10.89–19),P=0.036。
- AFMR与PMR的左房纵向应变峰值分别为16.86±12.15%和23.67±14.09%,P=0.002。
- AFMR与PMR接受二尖瓣干预的比例分别为59.0%和83.6%,P=0.001。
临床应用与阅片要点
- 对重度MR伴左室功能保留者,应结合瓣叶形态区分AFMR与PMR,无瓣叶病变者考虑AFMR。
- AFMR患者需关注合并症(高血压、糖尿病、房颤、起搏器及非二尖瓣心脏手术史)。
- 超声评估可关注E/e'和左房纵向应变以辅助识别AFMR高危患者。
- AFMR患者治疗选择有限且干预率低,但手术与生存改善相关,需个体化评估。
局限性
- 单中心回顾性研究,样本量有限(283例),AFMR仅占14%。
- 以无瓣叶病变定义AFMR,可能存在分类偏倚。
- 随访中位22个月,长期结局未充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study was designed to compare the clinical and echocardiographic characteristics, management, and outcomes of severe atrial functional mitral regurgitation (AFMR) to primary mitral regurgitation (PMR).
BACKGROUND: AFMR remains poorly defined clinically.
METHODS: Consecutive patients who underwent transesophageal echocardiography at our institution between 2011 and 2018 for severe mitral regurgitation with preserved left ventricular function were screened. We excluded patients with endocarditis, any form of cardiomyopathy, or prior mitral intervention. The absence of leaflet pathology defined AFMR. Outcomes included death and heart failure hospitalizations.
RESULTS: A total of 283 patients were included (AFMR = 14%, PMR = 86%). Compared to PMR, patients with AFMR had more comorbidities, including hypertension (94.9% vs. 76.2%; p = 0.015), diabetes mellitus (46.2% vs. 18.4%; p < 0.001), long-standing atrial fibrillation (28.2% vs. 13.1%; p = 0.015), prior nonmitral cardiac surgery (25.6% vs. 9.8%; p = 0.004), and pacemaker placement (33.3% vs. 13.5%; p = 0.002). They also had higher average E/e' (median [interquartile range]:16.04 [13.1 to 22.46] vs. 14.1 [10.89 to 19]; p = 0.036) and worse longitudinal left atrial strain peak positive value (16.86 ± 12.15% vs. 23.67 ± 14.09%; p = 0.002) compared to PMR. During follow-up (median: 22 months), patients with AFMR had worse survival (log-rank p = 0.009) and more heart failure hospitalizations (log-rank p = 0.002). They were also less likely to undergo mitral valve intervention (59.0% vs. 83.6%; p = 0.001), although surgery was associated with improved survival (log-rank p = 0.021). On multivariable regression analysis, AFMR was independently associated with mortality [adjusted odds ratio: 2.61, 95% confidence interval: 1.17 to 5.83; p = 0.02].
CONCLUSIONS: AFMR constitutes an under-recognized high-risk group, with significant comorbidities, limited therapeutic options, and poor outcomes.
引用
- Mesi O, Gad MM, Crane AD, et al. Severe Atrial Functional Mitral Regurgitation: Clinical and Echocardiographic Characteristics, Management and Outcomes. JACC Cardiovasc Imaging. 2021. PMID: 33832663. doi:10.1016/j.jcmg.2021.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。